Clinical Trial Update: Absorption and Systematic Pharmacokinetics of IDP-123 Lotion in Comparison With Tazorac Cream [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating the absorption and systemic pharmacokinetics of IDP-123 Lotion compared with Tazorac Cream in acne; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• IDP-123 Lotion
• Tazorac Cream (tazarotene)

Snippet

Sponsor: Bausch Health Americas, Inc. | Conditions: Acne | Phase 1 | Status: COMPLETED